Investor Relations

INVESTORS & MEDIA

INVESTORS
& MEDIA

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in seven FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.

 

 

NEWSROOM

  • Jan 07

    Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference
  • Jan 07

    Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs

EVENTS

Events
More events are coming soon.